Novartis broke ground on a new, state-of-the-art global Biomedical Research center in San Diego, designed to provide world-class scientific infrastructure and drug-discovery capabilities to advance the company’s pipeline for patients.
Once operational in 2029, the approximately 466,000-square-foot facility is expected to house about 1,000 Novartis employees and integrate seamlessly with Novartis global research sites including Cambridge, Massachusetts, and Basel, Switzerland.
Novartis first established its San Diego presence in 1999 with the founding of the Genomics Institute of the Novartis Research Foundation (GNF), a center dedicated to advancing genomic science and accelerating innovation in drug discovery.
View
View
View
View
